期刊文献+

类风湿关节炎合并间质性肺病患者血清中转化生长因子-β骨形成蛋白-4检测及其意义 被引量:6

The significance of serum concentrations of transforming growth factor-β1 and bone morphogeneticprotein-4 in patients with rheumatoid arthritis and interstitial lung disease
原文传递
导出
摘要 目的探讨类风湿关节炎(RA)合并间质性肺病(ILD)患者的临床特点和转化生长因子(TGF)-β1、骨形成蛋白(BMP)-4在血清中的水平。方法入选28例RA-ILD患者、32例单纯RA患者和20名健康对照,RA-ILD组进一步分为早期组(16例)和中晚期组(12例),酶联免疫吸附试验(ELISA)法测定血清中TGF-β1、BMP-4水平,并分析血清TGF-β1、BMP-4水平与实验室指标的相关性。采用t检验、单因素方差分析及Spearman相关分析法进行数据分析。结果与单纯RA患者相比,RA-ILD组患者初次发生关节炎时年龄较大,关节功能优于单纯RA组患者,血清类风湿因子(RF)滴度高(P〈0.05,P〈0.05,P〈0.01),出现肺间质病变时间为2-6年,平均(3.0±1.2)年。TGF-β1水平在RA-ILD组稍增高,但3组相比差异无统计学意义(P〉0.05)。早期RA-ILD组患者TGF-β1血清水平明显增高,与中晚期RA.ILD组及单纯RA组、健康对照组相比较差异均有统计学意义(P<0.01)。RA-ILD组患者BMP-4水平低于单纯RA组及健康对照组,差异有统计学意义(P〈0.05),且早期RA-ILD组患者BMP-4水平显著下降,与中晚期RA-ILD组及单纯RA组、健康对照组相比较差异均有统计学意义(P〈0.05)。血清BMP-4水平与TGF-β1水平之间无相关性(p〉0.05),血清TGF-β1、BMP-4水平与实验室指标红细胞沉降率、C反应蛋白、RF、抗环瓜氨酸肽(CCP)抗体等均无明显相关性(P均〉O.05)。结论在早期RA-ILD患者中血清TGF-β1水平增高,BMP-4水平减低,二者可能参与了RA患者ILD的发生。 Objective To compare the serum levels of transforming growth factor (TGF)-beta 1, bone morphogenetic protein (BMP)-4 in patients with rheumatoid arthritis (RA) and RA with interstitial lung disease (RA-ILD). Methods Twenty-eight RA-ILD patients, 32 patients with RA but without ILD and 20 normal controls were enrolled. The RA-ILD group was further divided into early group and late group. All the observed subjects were analyzed using enzyme linked immunosorbent assay (ELISA) for the determination of serum TGF-β1 and BMP-4 levels. The relationship between the serum levels of TGF-β1, BMP-4 and laboratory examinations were investigated. Comparisions between groups were tested by one-way ANOVA analysis and ttest. Correlation of indexs were observed by Spearman method. Results Patients in the RA-ILD group were older than RA group in disease onset age, in addition, patients with ILD had better joint function and higher serum rheumatoid factor titers. The occurrence time of interstitial lung disease was 2-6 years after the onset of arthritis, with an average time of (3.0±1.2) years. The TGF-β1 levels in the RA-ILD group were slightly higher, but not statistically significant than other groups (P〉0.05). The TGF-β1 serum levels in the early RA-ILD patients were significantly increased than those of the late RA-ILD group and the RA group. BMP-4 levels in patients with RA-ILD group were less than RA without ILD group and healthy control group, and the differ- ence was statistically significant (P〈0.05). BMP-4 level in early RA-ILD group was significantly decreased than those of the late RA-ILD group and RA group. No correlation between the serum BMP-4, TGF-β1 level (P〉0.05) no assay result correlated with laboratory parameters including ESR, CRP, RF and anti-CCPantibodies (P〉0.05). Conclusion TGF-β1 serum levels are increased and BMP-4 levels are decreased in early RA-ILD patients. The serum levels of TGF-β1 and BMP-4 may be indicatior for asymptomatic ILD and reflect disease progression.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2012年第8期545-548,共4页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 肺病 间质性 转化生长因子β 骨形成蛋白-4 Arthritis, rheumatoid Lung diseases, interstitial Transforming growth factor beta Bonemorphogenetic protein-4
  • 相关文献

参考文献12

  • 1Bartram U, Speer CP. The role of transforming growth factor-b in lung development and disease. Chest, 2004, 125: 754-765.
  • 2Bellusci S, Henderson R, Winnier G, et al. Evidence from normal expression and targeted misexpression that bone mor- phogenetic protein (BMP-4) plays a role in mouse embryonic lung morphogenesis. Development, 1996, 122: 1693-1702.
  • 3Dawson JK, Fewins HE, Desmond J, et al. Predictors of pro-gression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis, 2002, 61: 517-521.
  • 4Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an incep- tion cohort. Rheumatology (Oxford), 2010, 49: 1483-1489.
  • 5Khalil N, Xu YD, O'Connor R, et al. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor- betal-indueed release of extraeellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem, 2005, 280: 43000-43009.
  • 6Chen D, Zhao M, Mundy GR, et al. Bone morphogenetic pro- teins. Growth Factors, 2004, 22: 233-241.
  • 7Xu YD, Hua J, Mui A, et al. Release of biologically active TGF-β by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2003, 285: 527-539.
  • 8Jeffery TK, Upton PD, Trembath RC, et al. BMP4 inhibits proliferation and promotes myocyte differentiation of lung fi- broblasts via Smadl and JNK pathways. Am J Physiol Lung Cell Mol Physiol, 2005, 288: 370-378.
  • 9Koli K, Wempe F, Sterner-Kock A, et al. Disruption of LTBP-4 function reduces TGF-13t activation and enhances BMP-4 signal- ing in the lung. J Cell Biol, 2004, 167: 123-133.
  • 10Koli K, Myllarniemi M, Vuorinen K, et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pul- monary fibrosis. Am J Pathol, 2006, 169: 61-71.

二级参考文献13

  • 1Gauhar UA, Gaffo AL, Alarcon GS. Pulmonary manifestations of rheumatoid arthritis. Semin Respir Crit Care Med, 2007,28:430- 440.
  • 2Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol, 2007,36 : 172-178.
  • 3Afeltra A, Zennaro D, Garzia P, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol, 2006,35:388-394.
  • 4Brown KK. Rheumatoid lung disease. Proc Am Thorae Soc,2007, 15:443-448.
  • 5Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med, 2007,28:369- 378.
  • 6Liu R, Ahmed KM, Nantajit D, et al. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats. Int J Mol Med ,2007,19:865-873.
  • 7Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, et al. Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol, 2006, 25:213-218.
  • 8Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum, 2005, 53:549-557.
  • 9Biederer J, Sehnabel A, Muhle C, et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis,2004, 14:272-280.
  • 10Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum, 2006, 54 : 1435-1439.

共引文献11

同被引文献49

  • 1Tschauner C ,Ftirntrath F,Saba Y,et al. Developmental dysplasia of the hip: impact of sonographic newborn hip screening on the outcome of early treated decentered hip joints-a single center retrospective comparative cohort study based on Graf's method of hip uhrasonogra- phy [J]. J Child Orthop,2011,5(6) :415-424.
  • 2Semenowicz J, Szymafiski S, Walo R, et al. Total hip arthroplasty with shortening subtrochanteric Z osteotomy in the treatment of develop- mental dysplasia with high hip dislocation [J]. Ortop Traumatol Reha- bi1,2012,14(4) :341-349.
  • 3Yau CH,Choi KY,Kwong NS,et al. Frequency of developmental dysplasia of the hip in breech-presented Chinese neonates in Hong Kong [J]. Hong Kong Med J,2012,18(5):407-411.
  • 4Zou YQ,Li YS,Ding XN,et al.The clincal significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease:areport from china[J].Rheumatology intern,2012,32(3):669-673.
  • 5Wang JX,Du CG.A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients[J].Med Sci Monit,2015,7(21):708-715.
  • 6Kelly CA,Saravanan V,Nisar M,et al.Rheumatoid arthritis-related interstitial lung disease:associations,prognostic factors and physiological and radiological characteristics-a large multicentre UK study[J].Rheumatology(Oxford),2014,53(9):1676-1682.
  • 7Hasegawa M,Matsushita Y,Horikawa M,et al.A novel inhibitor of Smad-deendent transcriptional activation suppresses tissue fibrosis in mouse models of sysemic sclerosis[J].Arthritis Rheum,2009,60(11):3465-3475.
  • 8Szlubowski A,Soja J,Grzanka P,et al.TGF-beta1inbronchoalveolar lavage fluid in diffuse parenchymal lung diseases and high-resolution computed tomography score[J].Pol Arch Med Wewn,2010,120(7-8):270-275.
  • 9Furukawa H,Oka S,Shimada K,et al.Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis:aprotective role for shared epitope[J].PLoS One,2012,7(5):e33133.
  • 10Assayag D,Lubin M,Lee JS,et al.Predictors of mortality in rheumatoid arthritis-related interstitial lung disease[J].Respirology,2014,19(4):493-500.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部